ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 川崎医学会機関誌
  2. Kawasaki Medical Journal
  3. Vol.48(2022)

Changes in serum antibody titers after vaccination for COVID-19 and evaluation of post-vaccination health conditions

https://kwmed.repo.nii.ac.jp/records/3057
https://kwmed.repo.nii.ac.jp/records/3057
72183258-688b-4a0c-9f3b-30a88cb50a08
名前 / ファイル ライセンス アクション
KMJ-E202248073.pdf PDF (1.4 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2023-03-10
タイトル
タイトル Changes in serum antibody titers after vaccination for COVID-19 and evaluation of post-vaccination health conditions
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 OHIRA, Shin

× OHIRA, Shin

en OHIRA, Shin

Search repository
NAKANO, Takashi

× NAKANO, Takashi

en NAKANO, Takashi

Search repository
UESUGI, Satoe

× UESUGI, Satoe

en UESUGI, Satoe

Search repository
KOUGUCHI, Yutaka

× KOUGUCHI, Yutaka

en KOUGUCHI, Yutaka

Search repository
TAMURA, Masayo

× TAMURA, Masayo

en TAMURA, Masayo

Search repository
HIRAMATSU, Takako

× HIRAMATSU, Takako

en HIRAMATSU, Takako

Search repository
ATARASHI, Mihoe

× ATARASHI, Mihoe

en ATARASHI, Mihoe

Search repository
NAKATSUKA, Tota

× NAKATSUKA, Tota

en NAKATSUKA, Tota

Search repository
HIRATA, Keita

× HIRATA, Keita

en HIRATA, Keita

Search repository
TANAKA, Takaaki

× TANAKA, Takaaki

en TANAKA, Takaaki

Search repository
KIMURA, Tomohiko

× KIMURA, Tomohiko

en KIMURA, Tomohiko

Search repository
KANDA, Eiichiro

× KANDA, Eiichiro

en KANDA, Eiichiro

Search repository
TOHYAMA, Kaoru

× TOHYAMA, Kaoru

en TOHYAMA, Kaoru

Search repository
OTOMO, Takanobu

× OTOMO, Takanobu

en OTOMO, Takanobu

Search repository
NAGAI, Atsushi \n

× NAGAI, Atsushi \n

en NAGAI, Atsushi \n

Search repository
著者所属(英)
言語 en
値 Department of Urology, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Pediatrics, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Clinical Laboratory, Kawasaki Medical School Hospital
著者所属(英)
言語 en
値 Department of Clinical Laboratory, Kawasaki Medical School Hospital
著者所属(英)
言語 en
値 Department of Clinical Laboratory, Kawasaki Medical School General Medical Center
著者所属(英)
言語 en
値 Department of Nursing, Kawasaki Medical School Hospital
著者所属(英)
言語 en
値 Department of Nursing, Kawasaki Medical School General Medical Center
著者所属(英)
言語 en
値 Department of Urology, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Urology, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Pediatrics, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School
著者所属(英)
言語 en
値 Medical Science, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Laboratory Medicine, Kawasaki Medical School
著者所属(英)
言語 en
値 Department of Molecular and Genetic Medicine, Kawasaki Medical School
著者所属(英)
言語 en
値 Director of Kawasaki Medical School Hospital
キーワード
言語 en
主題Scheme Other
主題 COVID-19 vaccine
キーワード
言語 en
主題Scheme Other
主題 Introduction of vaccination
キーワード
言語 en
主題Scheme Other
主題 Serum antibody titer
キーワード
言語 en
主題Scheme Other
主題 Health condition survey
抄録(英)
言語 en
値 Introduction: The coronavirus disease 2019 (COVID-19) vaccine has preventive effects and high immunogenicity, but the outcomes of vaccination have not been widely reported. The goal of this study was to examine serum antibody titers before and after vaccination and to evaluate post-vaccination health conditions.
 Methods: The subjects were 2,304 medical workers (mean age 41 years) at Kawasaki Gakuen who agreed to participate in the study and underwent COVID-19 vaccination, beginning in March 2021. Serum IgG antibody titers for SARS-CoV-2 spike protein were measured before the first vaccination and 4 weeks after the second vaccination. Health conditions were observed for 4 weeks after the second vaccination.
 Results: The rates of seroconversion, seroprotection, and change in geometric mean antibody titer at 4 weeks after the second vaccination were 99.9%, 99.9%, and 2,685.5 (95% CI 587.8-5,319.2), respectively, suggesting high immunogenicity. After the first vaccination, pain, enlargement, and reddening occurred at the local injection site, and systemic side effects included fatigue, headache, physical pain, chill, nausea, and fever. After the second vaccination, the incidence of pain decreased, but those of other events increased. There were no serious side effects requiring hospitalization. In logistic regression analysis, sex, age, fever,chill, and lymph node enlargement after the second vaccination were associated with a change in antibody titer.
 Conclusions: Serum antibody titers suggested high immunogenicity of the COVID-19 vaccine and a health condition survey confirmed the safety of the vaccine. Systemic side effects may serve as an index of immunization (acquisition of antibody) by the vaccine.
書誌情報 en : Kawasaki medical journal

巻 48, p. 73-85, 発行日 2022
出版者
出版者 Kawasaki Medical Society
ISSN
収録物識別子タイプ EISSN
収録物識別子 24343404
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AA12029005
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.11482/KMJ-E202248073
記事種別(英)
内容記述 Regular Article
言語 en
関連サイト
識別子タイプ URI
関連識別子 https://igakkai.kms-igakkai.com/wp/wp-content/uploads/2022en/KMJ-E202248073.pdf
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-19 10:48:21.038697
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3